Art

J-GLOBAL ID：202202248580063230   Reference number：22A1021382

Abnormalities of Electroencephalography Microstates in Drug-Naieve, First-Episode Schizophrenia

薬物未投与,初回エピソード統合失調症における脳波微小状態の異常【JST・京大機械翻訳】

Author (3)： Sun Qiaoling (Department of Psychiatry, National Clinical Research Center for Mental Disorders, China National Technology Institute on Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, China) ,  Zhao Linlin (Department of Psychiatry, National Clinical Research Center for Mental Disorders, China National Technology Institute on Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, China) ,  Tan Liwen (Department of Psychiatry, National Clinical Research Center for Mental Disorders, China National Technology Institute on Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, China)
Material： Frontiers in Psychiatry (Web)
Volume： 13  Page： 853602  Publication year： 2022 
JST Material Number： U7095A  ISSN： 1664-0640  Document type： Article
Article type： 原著論文  Country of issue： Switzerland (CHE)  Language： ENGLISH (EN)

Abstract/Point： Objective: Microstate analysis...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=22A1021382&from=J-GLOBAL&jstjournalNo=U7095A") }}

Thesaurus term： *electroencephalogram ,  *schizophrenia ,  neurophysiology ,  patient ,  function(performance) ,  mental manifestation ,  human(sociology) ,  bed rest
Semi thesaurus term： 陽性陰性症状評価尺度 ,  早期治療介入 ,  脳機能 ,  陽性症状 ,  *初発統合失調症 , 【Automatic Indexing@JST】

Author keywords (5)： drug-naieve ,  first-episode schizophrenia ,  resting-state ,  EEG ,  microstate

JST classification (2)： Biometry  (EL03020C) ,  Neurologic diagnosis  (GN02000H)

Reference (56)：

• GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet. (2017) 390:1211-59. doi: 10.1016/S0140-6736(17)32154-2
• Goff DC. The pharmacologic treatment of schizophrenia-2021. JAMA. (2021) 325:175-6. doi: 10.1001/jama.2020.19048
• Charlson FJ, Ferrari AJ, Santomauro DF, Diminic S, Stockings E, Scott JG, et al Global epidemiology and burden of schizophrenia: findings from the global burden of disease study 2016. Schizophr Bull. (2018) 44:1195-203. doi: 10.1093/schbul/sby058
• Galderisi S, Rucci P, Mucci A, Rossi A, Rocca P, Bertolino A, et al The interplay among psychopathology, personal resources, context-related factors and real-life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non-recovered patients. World Psychiatry. (2020) 19:81-91. doi: 10.1002/wps.20700
• Galderisi S, Rucci P, Kirkpatrick B, Mucci A, Gibertoni D, Rocca P, et al Interplay among psychopathologic variables, personal resources, context-related factors, and real-life functioning in individuals with schizophrenia: a network analysis. JAMA Psychiatry. (2018) 75:396-404. doi: 10.1001/jamapsychiatry.2017.4607

Terms in the title (5)： 薬物 ,  投与 ,  初回エピソード統合失調症 ,  脳波 ,  微小